tiprankstipranks
Trending News
More News >
Qualigen Therapeutics Inc (QLGN)
:QLGN
US Market
Advertisement

Qualigen Therapeutics (QLGN) Income Statement

Compare
657 Followers

Qualigen Therapeutics Income Statement

Last quarter (Q4 2024), Qualigen Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Qualigen Therapeutics's net income was $-855.82K. See Qualigen Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 5.20M$ 4.98M$ 5.65M$ 4.31M
Gross Profit
$ 0.00$ -4.50K$ 680.80K$ 1.32M$ -2.88M
Operating Expenses
$ 5.76M$ 6.10M$ 18.62M$ 23.98M$ 17.40M
Depreciation and Amortization
$ 0.00$ 4.50K$ 12.16K$ 322.06K$ 138.65K
EBITDA
$ -5.24M$ -11.30M$ -13.84M$ -22.66M$ -11.16M
Operating Income
$ -5.76M$ -11.30M$ -17.94M$ -22.66M$ -11.30M
Other Income/Expenses
$ -391.14K$ -1.17M$ 872.81K$ 4.77M$ -7.74M
Pretax Income
$ -6.15M$ -12.48M$ -21.30M$ -17.89M$ -20.42M
Net Income
$ -6.16M$ -13.42M$ -21.03M$ -17.90M$ -20.42M
Per Share Metrics
Basic EPS
$ -17.28$ -2.46$ -5.48$ -6.10$ -7.98
Diluted EPS
$ -17.28$ -2.46$ -5.48$ -6.10$ -7.89
Weighted Average Shares Outstanding
361.59K 5.07M 3.84M 2.93M 2.56M
Weighted Average Shares Outstanding (Diluted)
361.59K 5.07M 3.84M 2.93M 2.59M
Currency in USD

Qualigen Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis